Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
DKSH to provide Market Expansion Services for Nestle's Materna in China 2015-01-09 14:00
New class of antibiotics - bioengineered to deter the development of antibiotic resistance 2015-01-09 04:29
Turkish Life Sciences Industry Fuelled by Favourable Investment Climate and Healthcare Reforms 2015-01-08 20:43
LEO Pharma Announces US Regulatory Submission of the First Aerosol Foam for Psoriasis 2015-01-06 13:01
Technology Center of Infinitus Yingkou Production Base Officially Unveiled 2014-12-31 14:54
Janssen Announces Collaboration with Gilead to Develop PREZISTA(R)-based Single-tablet Regimen for the Treatment of People Living with HIV 2014-12-29 21:30
Frost & Sullivan New Product Innovation Award Conferred on Protein Sciences Corporation for Flublok® Influenza Vaccine 2014-12-29 17:00
Lilly Announces Diabetes Research Partnership with University of Surrey 2014-12-22 23:51
Eiger Bio Receives Orphan Designation for Lonafarnib, a First In Class, Investigational Treatment for Hepatitis Delta Virus (HDV) Infection 2014-12-22 21:00
Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib -- Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2014-12-22 21:00
Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study 2014-12-19 22:00
Aptuit Adds Hot Melt Extrusion Technology To Its Integrated API And Formulation Development Expertise 2014-12-18 03:27
Kinex Pharmaceuticals Appoints Chief Operating Officer 2014-12-17 23:42
LKK Health Products Group Promotes Industrial Ecosystem 2014-12-12 09:00
LKK Health Products Group Promotes Industrial Ecosystem 2014-12-12 09:00
Mundipharma Donates BETADINE Anti-viral Supplies to Direct Relief to Support the Fight Against Ebola in West Africa 2014-12-11 17:18
Zydus Launches World's First Biosimilar of Adalimumab 2014-12-09 19:01
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting 2014-12-09 09:30
Takeda Presents Phase 2 Data on Maintenance with Single-Agent Investigational Ixazomib in Patients with Newly Diagnosed Multiple Myeloma 2014-12-09 09:30
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS(R) (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting 2014-12-09 09:30
1 157 158 159 160 161 165